By analysing DNA from blood samples, Tvaster Genkalp is working to make cancer diagnostics more accessible, accurate, and ...

Solute carrier family 25 member 19 (SLC25A19) is a transporter protein of thiamine pyrophosphate across cellular membranes, which is needed as a cofactor for multiple metabolic enzymes and is ...

A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...

Hepatocellular carcinoma (HCC) is a common malignant tumor and the third leading cause of cancer-related mortality. The lack ...

RT-PCR test quantifying CP mRNA in blood can detect hepatocellular carcinoma early—especially in AFP-negative cases—offering ...

Hepatocellular carcinoma (HCC) represents the most prevalent ... circRNAs have been observed in several genetic studies to play a vital role in the initiation and progression of malignancy.

Hepatocellular carcinoma (HCC) represents the most prevalent ... circRNAs have been observed in several genetic studies to play a vital role in the initiation and progression of malignancy.

Prostate cancer has distinct genetic properties in different groups of men that can be targeted to improve patient outcomes, UVA Cancer Center researchers have discovered. Based on new findings in ...

Although we have yet to identify a definitive genetic marker for TGCTs, studies like this pave the way for more personalised approaches to cancer prevention and treatment.” The lack of replication in ...

Statins appeared to reduce the risk for hepatocellular carcinoma and hepatic decompensation among patients with chronic liver disease, according to findings in JAMA Internal Medicine.

Hepatocellular carcinoma (HCC) is a major global health challenge ... Immunohistochemical staining and exosomal IFITM3 analysis were applied to evaluate gene expression across treatment stages.